These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 8631031

  • 41. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 42. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
    Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ.
    Cancer Res; 1994 Jul 15; 54(14):3758-65. PubMed ID: 7913407
    [Abstract] [Full Text] [Related]

  • 43. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J.
    Clin Cancer Res; 1997 Nov 15; 3(11):2099-106. PubMed ID: 9815602
    [Abstract] [Full Text] [Related]

  • 44. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
    Tannheimer SL, Rehemtulla A, Ethier SP.
    Breast Cancer Res; 2000 Nov 15; 2(4):311-20. PubMed ID: 11056689
    [Abstract] [Full Text] [Related]

  • 45. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW, Stonecypher MS, Carroll SL.
    Glia; 2003 Aug 15; 43(2):104-18. PubMed ID: 12838503
    [Abstract] [Full Text] [Related]

  • 46. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R, Dickson RB, Lippman ME.
    Princess Takamatsu Symp; 1991 Aug 15; 22():49-60. PubMed ID: 1688228
    [Abstract] [Full Text] [Related]

  • 47. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP.
    Oncogene; 2005 Apr 28; 24(19):3177-86. PubMed ID: 15735691
    [Abstract] [Full Text] [Related]

  • 48. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 49. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS, Ho CT, Ho YS, Lin JK.
    Toxicol Appl Pharmacol; 2007 Jan 15; 218(2):107-18. PubMed ID: 17182072
    [Abstract] [Full Text] [Related]

  • 50. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y.
    EMBO J; 1996 Jan 15; 15(2):254-64. PubMed ID: 8617201
    [Abstract] [Full Text] [Related]

  • 51. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.
    Shawver LK, Mann E, Elliger SS, Dugger TC, Arteaga CL.
    Cancer Res; 1994 Mar 01; 54(5):1367-73. PubMed ID: 7907001
    [Abstract] [Full Text] [Related]

  • 52. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
    Hines SJ, Organ C, Kornstein MJ, Krystal GW.
    Cell Growth Differ; 1995 Jun 01; 6(6):769-79. PubMed ID: 7545433
    [Abstract] [Full Text] [Related]

  • 53. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R.
    Oncogene; 1996 Apr 18; 12(8):1679-87. PubMed ID: 8622888
    [Abstract] [Full Text] [Related]

  • 54. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
    deFazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL.
    Int J Cancer; 2000 Aug 15; 87(4):487-98. PubMed ID: 10918187
    [Abstract] [Full Text] [Related]

  • 55. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
    Hudelist G, Singer CF, Manavi M, Pischinger K, Kubista E, Czerwenka K.
    Breast Cancer Res Treat; 2003 Aug 15; 80(3):353-61. PubMed ID: 14503808
    [Abstract] [Full Text] [Related]

  • 56. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells.
    Ethier SP, Moorthy R, Dilts CA.
    Cell Growth Differ; 1991 Nov 15; 2(11):593-602. PubMed ID: 1726054
    [Abstract] [Full Text] [Related]

  • 57. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
    Miller DL, el-Ashry D, Cheville AL, Liu Y, McLeskey SW, Kern FG.
    Cell Growth Differ; 1994 Dec 15; 5(12):1263-74. PubMed ID: 7696175
    [Abstract] [Full Text] [Related]

  • 58. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
    Ethier SP, Mahacek ML, Gullick WJ, Frank TS, Weber BL.
    Cancer Res; 1993 Feb 01; 53(3):627-35. PubMed ID: 8425198
    [Abstract] [Full Text] [Related]

  • 59. Role of intracellular Ca2+ in the epidermal growth factor induced inhibition of protein tyrosine phosphatase activity in a breast cancer cell line.
    Mishra S, Hamburger AW.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1066-72. PubMed ID: 7682060
    [Abstract] [Full Text] [Related]

  • 60. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells.
    Dati C, Antoniotti S, Taverna D, Perroteau I, De Bortoli M.
    Oncogene; 1990 Jul 31; 5(7):1001-6. PubMed ID: 1973827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.